Mayne Pharma (MYX.AX) traded down -1.61 % during a 24 hours period ending at 12:26 AM Central Europe on Tuesday 27th. One Mayne Pharma stock can currently be bought for about AUD 2.48 on popular exchanges. Current supply of Mayne Pharma stocks is 81.9 mn. Mayne Pharma has a current market capitalization of AUD 200.6 mn and approximately AUD 253.8 k worth of Mayne Pharma was traded on exchanges in the last 24 hours. Since last month end, Mayne Pharma has traded -16.95 % down. Simple moving average of last 200 days is at AUD 2.68. The highest price of past 52 weeks was recorded at AUD 6.25 on 10/29/2025. 52 weeks low was at AUD 2.04 on 03/20/2026.
Here is how related stocks have performed in the past 24 hours:
Waterco (WAT.AX) traded up 0.07 % and now trades at AUD 6.85. Waterco has a market capitalisation of AUD 239.6 mn. Waterco has a current price to earnings ratio of 15.57.
Havilah (HAV.AX) traded down -9.93 % and now trades at AUD 0.68. Havilah has a market capitalisation of AUD 240.7 mn.
Ama (AMA.AX) traded up 4.17 % and now trades at AUD 0.47. Current market capitalisation for Ama is AUD 238.4 mn. Ama has a current price to earnings ratio of 34.53.
Northern Minerals (NTU.AX) traded flat 0 % and now trades at AUD 0.02. Northern Minerals has a market capitalisation of AUD 229.2 mn.
Paragon Care (PGC.AX) traded down -3.33 % and now trades at AUD 0.16. Paragon Care has a market capitalisation of AUD 240 mn.
About Mayne Pharma
The Mayne Pharma Group Ltd. is a health care sector company with its base in Salisbury South, Australia. It specializes in the development and manufacturing of oral pharmaceuticals. The company produces branded generics, specialty generics, and active pharmaceutical ingredients. You can find more information about their offerings on their website, www.maynepharma.com , and they are listed on the ASX All Markets. Their Initial Public Offering (IPO) date back to June 29, 2007.